Aspira Women's Health Inc.
AWHL
$0.32
$0.013.23%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 1.97M | 2.23M | 2.31M | 2.40M | 2.28M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.97M | 2.23M | 2.31M | 2.40M | 2.28M |
| Cost of Revenue | 896.00K | 790.00K | 922.00K | 870.00K | 719.00K |
| Gross Profit | 1.07M | 1.44M | 1.38M | 1.53M | 1.56M |
| SG&A Expenses | 2.10M | 2.31M | 2.25M | 2.67M | 3.83M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.17M | 3.51M | 3.88M | 4.21M | 5.52M |
| Operating Income | -2.20M | -1.28M | -1.58M | -1.81M | -3.24M |
| Income Before Tax | 676.00K | -3.37M | -4.89M | -2.67M | -1.85M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 676.00K | -3.37M | -4.89M | -2.67M | -1.85M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 676.00K | -3.37M | -4.89M | -2.67M | -1.85M |
| EBIT | -2.20M | -1.28M | -1.58M | -1.81M | -3.24M |
| EBITDA | -2.16M | -1.27M | -1.53M | -1.80M | -3.23M |
| EPS Basic | 0.02 | -0.08 | -0.13 | -0.08 | -0.09 |
| Normalized Basic EPS | 0.01 | -0.06 | -0.08 | -0.05 | -0.02 |
| EPS Diluted | -0.05 | -0.08 | -0.13 | -0.08 | -0.09 |
| Normalized Diluted EPS | 0.01 | -0.06 | -0.08 | -0.05 | -0.02 |
| Average Basic Shares Outstanding | 43.49M | 42.80M | 36.39M | 35.56M | 21.59M |
| Average Diluted Shares Outstanding | 45.77M | 42.80M | 36.39M | 35.56M | 21.59M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |